Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for ENvue Medical, Inc. (FEED : NSDQ)

• Company Description    ENvue Medical Holdings Corp. is an electromagnetic navigation technology, providing real-time guidance for enteral feeding tube placement across critical care, step-down units and general medical-surgical floors in hospitals. ENvue Medical Holdings Corp., formerly known as NanoVibronix Inc., is based in ELMSFORD, N.Y. Number of Employees: 31

• Price / Volume Information    Yesterday's Closing Price: $2.31 Daily Weekly Monthly 20 Day Moving Average: 22,477 shares Shares Outstanding: 1.09 (millions) Market Capitalization: $2.51 (millions) Beta: 2.09 52 Week High: $88.20 52 Week Low: $2.09 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -43.52% -43.42% 12 Week -66.93% -67.46% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 969 PRUITT AVE - TYLER,TX 77569 USA ph: 914-233-3004 fax: 914-376-6111 ir@taosynergies.com http://www.nanovibronix.com

• General Corporate Information    Officers Brian Murphy - Chief Executive Officer and Director Christopher Fashek - Chairman of the Board Stephen Brown - Chief Financial Officer Martin Goldstein - Director Doron Besser - Director Peer Information ENvue Medical, Inc. (ABMD) ENvue Medical, Inc. (DMDS) ENvue Medical, Inc. (CPWY.) ENvue Medical, Inc. (EQUR) ENvue Medical, Inc. (ECIA) ENvue Medical, Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 63008J884 SIC: 3842 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 03/30/26 Share - Related Items Shares Outstanding: 1.09 Most Recent Split Date: 8.00 (0.10:1) Beta: 2.09 Market Capitalization: $2.51 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/30/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.06 Price/Cash Flow: - Price / Sales: 0.94 EPS Growth vs. Year Ago Period: 97.70% vs. Previous Quarter: 11.65% Sales Growth vs. Year Ago Period: 92.02% vs. Previous Quarter: 46.15% ROE 12/31/25 - - 09/30/25 - -24.78 06/30/25 - -45.24 ROA 12/31/25 - - 09/30/25 - -19.24 06/30/25 - -34.24 Current Ratio 12/31/25 - - 09/30/25 - 0.86 06/30/25 - 1.05 Quick Ratio 12/31/25 - - 09/30/25 - 0.67 06/30/25 - 0.72 Operating Margin 12/31/25 - - 09/30/25 - -275.12 06/30/25 - -380.29 Net Margin 12/31/25 - - 09/30/25 - -275.12 06/30/25 - -380.29 Pre-Tax Margin 12/31/25 - - 09/30/25 - -270.76 06/30/25 - -376.66 Book Value 12/31/25 - - 09/30/25 - 42.00 06/30/25 - 51.41 Inventory Turnover 12/31/25 - - 09/30/25 - 0.87 06/30/25 - 0.73 Debt-to-Equity 12/31/25 - - 09/30/25 - 0.00 06/30/25 - 0.00 Debt-to-Capital 12/31/25 - - 09/30/25 - 0.00 06/30/25 - 0.00

Powered by Zacks Investment Research ©